May 31, 2023 Comments Off on New patent for XERIS drug GVOKE HYPOPEN Posted in: Patent Added Annual Drug Patent Expirations for GVOKE+HYPOPEN Gvoke Hypopen is a drug marketed by Xeris and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent for XERIS drug GVOKE HYPOPEN appeared first on DrugPatent…
May 31, 2023 Comments Off on Which pharmaceutical companies have the most SPCs in Estonia? Posted in: Infographic This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Estonia. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
